WHO ICTRP trial
Efficacy of Aloe vera capsule versus omeprazole in the 4 weeks treatment of…
TCTR20211102002 · Thai Clinical Trials Registry (TCTR) · Recruiting
Key facts
| Trial ID | TCTR20211102002 |
|---|---|
| Public title | Efficacy of Aloe vera capsule versus omeprazole in the 4 weeks treatment of symptomatic gastroesophageal reflux disease |
| Scientific title | Efficacy of Aloe vera capsule versus omeprazole in the 4 weeks treatment of symptomatic gastroesophageal reflux disease |
| Primary sponsor | Dhurakij Pundit University |
| Registry | Thai Clinical Trials Registry (TCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | Thailand |
| Conditions | Patient who was diagnosed with symptomatic gastroesophageal reflux disease in the primary care center ( Bang Phae Hospital, Ratchaburi) gastroesophageal reflux disease (GERD), Omeprazole, Aloe vera;gastroesophageal reflux disease (GERD)… |
| Interventions | Aloe vera 70 mg per day after breakfast for 28 days (daily ) ,Oral omeprazole 20 mg per day before breakfast for 28 days (daily) ;Active Comparator Dietary Supplement,Experimental Drug;Aloe vera soft capsule,Omeprazole |
| Registration date | Feb 11, 2021 |
| Target size | 40 |
| Secondary IDs | 047/63EX |
| Registry page | thaiclinicaltrials.org |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: